123 related articles for article (PubMed ID: 6683185)
21. Requirement of a reactive aldehyde moiety for aldehyde-mediated protection against cis-dichlorodiammineplatinum-induced cell inactivation.
Dornish JM; Pettersen EO
Biochem Pharmacol; 1990 Jan; 39(2):309-18. PubMed ID: 2302256
[TBL] [Abstract][Full Text] [Related]
22. Modulation of cis-dichlorodiammineplatinum(II)-induced cytotoxicity by benzaldehyde derivatives.
Dornish JM; Pettersen EO
Cancer Lett; 1989 Jul; 46(1):63-8. PubMed ID: 2736510
[TBL] [Abstract][Full Text] [Related]
23. Antiproliferative activity of protocatechualdehyde on Chinese hamster cells grown in culture.
Nishimura M; Umeda M; Kusanagi A; Urakabe R; Yukimatsu K; Otawara S
Gan; 1981 Dec; 72(6):868-79. PubMed ID: 7341336
[TBL] [Abstract][Full Text] [Related]
24. Effect of benzaldehyde on the proliferation of HeLa cells.
Nambata T; Terada N; Takeuchi S
Gan; 1981 Apr; 72(2):289-92. PubMed ID: 7286550
[TBL] [Abstract][Full Text] [Related]
25. Radiation and taxol effects on synchronized human cervical carcinoma cells.
Geard CR; Jones JM
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):565-9. PubMed ID: 7911795
[TBL] [Abstract][Full Text] [Related]
26. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells.
Sutherland RL; Hall RE; Taylor IW
Cancer Res; 1983 Sep; 43(9):3998-4006. PubMed ID: 6871841
[TBL] [Abstract][Full Text] [Related]
27. The effect of NC-190, a novel antitumor compound, on the cell-cycle progression of HeLa S3 cells.
Yamagishi T; Nakaike S; Nanaumi K; Otomo S; Tsukagoshi S
Cancer Chemother Pharmacol; 1993; 32(4):249-54. PubMed ID: 8324865
[TBL] [Abstract][Full Text] [Related]
28. Effects of inhibition of RNA or protein synthesis on CHO cell cycle progression.
Traganos F; Kimmel M; Bueti C; Darzynkiewicz Z
J Cell Physiol; 1987 Nov; 133(2):277-87. PubMed ID: 2445763
[TBL] [Abstract][Full Text] [Related]
29. Cell cycle progression and radiation survival following prolonged hypoxia and re-oxygenation.
Koritzinsky M; Wouters BG; Amellem O; Pettersen EO
Int J Radiat Biol; 2001 Mar; 77(3):319-28. PubMed ID: 11258846
[TBL] [Abstract][Full Text] [Related]
30. Cell kinetic characteristics in different parts of multicellular spheroids of human origin.
Wibe E; Lindmo T; Kaalhus O
Cell Tissue Kinet; 1981 Nov; 14(6):639-51. PubMed ID: 7197587
[TBL] [Abstract][Full Text] [Related]
31. Effects of ellipticine on cell survival and cell cycle progression in cultured mammalian cells.
Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
Cancer Res; 1980 Jul; 40(7):2390-9. PubMed ID: 6155993
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of cell cycle progression of human pancreatic carcinoma cells in vitro by L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, Acivicin (NSC 163501).
Meck RA; Clubb KJ; Allen LM; Yunis AA
Cancer Res; 1981 Nov; 41(11 Pt 1):4547-53. PubMed ID: 7306976
[TBL] [Abstract][Full Text] [Related]
33. Cell killing, kinetics, and recovery responses induced by 1,2:5,6-dianhydrogalactitol in dividing and nondividiing cells in vitro.
Barranco SC; Flournoy DR
J Natl Cancer Inst; 1977 Mar; 58(3):657-63. PubMed ID: 839561
[TBL] [Abstract][Full Text] [Related]
34. Cell-cycle inhibitory effects of the mitotic inhibitor NY 3170 on human cells in vitro.
Wibe E; Oftebro R; Laland SG; Pettersen EO; Lindmo T
Br J Cancer; 1979 Apr; 39(4):391-7. PubMed ID: 444397
[TBL] [Abstract][Full Text] [Related]
35. [Flow cytometric analysis of the effect of THP-adriamycin on the cell cycle traverse of RPMI-8402 cells--comparison with adriamycin].
Takamoto S; Ota K
Gan To Kagaku Ryoho; 1986 May; 13(5):1868-75. PubMed ID: 3707149
[TBL] [Abstract][Full Text] [Related]
36. Regulation of cell proliferation under extreme and moderate hypoxia: the role of pyrimidine (deoxy)nucleotides.
Amellem O; Löffler M; Pettersen EO
Br J Cancer; 1994 Nov; 70(5):857-66. PubMed ID: 7947090
[TBL] [Abstract][Full Text] [Related]
37. Lethal and cytokinetic effects of mitomycin C on cultured human colon cancer cells.
Barlogie B; Drewinko B
Cancer Res; 1980 Jun; 40(6):1973-80. PubMed ID: 7371033
[TBL] [Abstract][Full Text] [Related]
38. Cellular effects of purvalanol A: a specific inhibitor of cyclin-dependent kinase activities.
Villerbu N; Gaben AM; Redeuilh G; Mester J
Int J Cancer; 2002 Feb; 97(6):761-9. PubMed ID: 11857351
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of the new mitotic inhibitor 5-chloropyrimidin-2-one and of vincristine on human cells in vitro.
Wibe E; Oftebro R; Christensen T; Laland SG; Pettersen EO; Lindmo T
Cancer Res; 1978 Mar; 38(3):560-5. PubMed ID: 626961
[No Abstract] [Full Text] [Related]
40. Cell cycle traverse in NHIK-3025 carcinoma of the uterine cervix after low-dose-rate irradiation.
van Oostrum IE; Rutgers DH
Radiat Res; 1989 Apr; 118(1):101-11. PubMed ID: 2704783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
